SCHEMBL21206186

SCHEMBL21206186

c1ccc(-c2ccc(-c3ccc(N(c4ccc(-c5cccc6ccccc56)cc4)c4cccc5sc6ccccc6c45)cc3)c3ccccc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F9 P00740 1/20 0.39
CA12 O43570 3/20 0.37
CA1 P00915 3/20 0.37
CA2 P00918 3/20 0.37
CA9 Q16790 3/20 0.37
TNF P01375 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
PPARG P37231 7/20 0.34
PPARA Q07869 7/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
PPARD Q03181 1/20 0.34
MCL1 Q07820 1/20 0.33
ACMSD Q8TDX5 1/20 0.33
CYP1A2 P05177 1/20 0.33
ENPP3 O14638 1/20 0.33
ENPP1 P22413 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21214807 0.99 F9 (0.39) F9CA12CA1CA2CA9
SCHEMBL18371336 0.96 CA12 (0.39) F9CA12CA1CA2CA9
SCHEMBL22837497 0.95 F9 (0.37) F9CA12CA1CA2CA9
SCHEMBL22255682 0.94 F9 (0.39) F9CA12CA1CA2CA9
SCHEMBL24999293 0.93 CA12 (0.39) F9CA12CA1CA2CA9
SCHEMBL21206083 0.93 F9 (0.34) F9CA12CA1CA2CA9
SCHEMBL22255649 0.93 F9 (0.34) F9CA12CA1CA2CA9
SCHEMBL23237922 0.93 F9 (0.38) F9CA12CA1CA2CA9
SCHEMBL21206193 0.92 F9 (0.36) F9MCL1SLC9A1MAPTTDP1
SCHEMBL21214777 0.92 F9 (0.39) F9CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11805697-B2 Organic electroluminescence device and monoamine compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-31 US disclosed
US-11805697-B2 Organic electroluminescence device and monoamine compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-31 US disclosed
US-20230055036-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO LTD (KR) 2023-02-23 US disclosed
EP-3518304-B1 N-(((PHENYL)NAPHTHALEN-2-YL)PHENYL)-N-(PHENYL)-DIBENZOTHIOPHENAMINE, -DIBENZOFURANAMINE AND -9H-FLUORENYLAMINE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN ORGANIC ELECTROLUMINESCENCE DEVICES SAMSUNG DISPLAY CO LTD (KR) 2021-11-03 EP disclosed
US-20190237676-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-08-01 US disclosed
EP-3518304-A1 N-(((PHENYL)NAPHTHALEN-2-YL)PHENYL)-N-(PHENYL)-DIBENZOTHIOPHENAMINE, -DIBENZOFURANAMINE AND -9H-FLUORENYLAMINE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN ORGANIC ELECTROLUMINESCENCE DEVICES Samsung Display Co., Ltd. (KR) 2019-07-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230055036-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLC18A2, SLC18A1, MAOA F9 2570/4885CA12 4498/4885CA1 4298/4885
US-11805697-B2 Organic electroluminescence device and monoamine compound for organic electroluminescence device SLC18A2, SLC18A1, MAOA F9 2570/4885CA12 4498/4885CA1 4298/4885
US-20190237676-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLC18A2, SLC18A1, MAOA F9 2570/4885CA12 4498/4885CA1 4298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.